The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 1/9

Austrian Health and Pharma Headlines

Austrian Subsidiaries of German Merck Get New CEO

Austrian distribution arms of German pharmaceutical firm Merck KGaA i.e. the Vienna-based firms Merck GesmbH, Merck Chemicals and Live Science GesmbH are getting a new helmsman in Matthias Wernicke.

June 30, 2015

Online Pharmaceutical Trade in Austria Starts on June 25th

As of 25th June national mail-order trade of OTC drugs via pharmacies will be possible in Austria, when the regulation comes in force.

June 22, 2015

Latvia's Silvanols Drug Company Begins Exports to Austria

Latvian pharmaceutical company Silvanols has started exports to Austria, the company announced. Silvanols has begun exporting Venocaps, a product for leg veins, in cooperation with Takeda Pharma Ges.m.g.H., the Austrian representation office of Japan’s Takeda Pharmaceutical Company Limited.

May 21, 2015

Valneva Profited from Crucell Acquisition in Q1

The listed biotech firm Valneva improved revenue and income in Q1 2015 thanks to the acquisition of Swedish Crucell. Sales hiked from EUR 7.1 to 19.5 million, whereas the company’s net loss of EUR 7.1 million (USD 7.9 million) was reduced to EUR 5 million. The comparative figures have not been adjusted though.

May 12, 2015

Baxter's Division, Baxalta, to Invest EUR 138 Million in Krems

International pharmaceutical and biotechnology giant Baxter under the name Baxalta will in the coming three years invest EUR 138 million (USD 156.7 million) in the expansion and modernization of production facility Krems. From 2018 the factory will be producing a medicine for blood clotting.

May 8, 2015

Antibiotics Company Nabriva Therapeutics Collects USD 120 Mln from Investors

Viennese biotech firm Nabriva Therapeutics, specialized in antibiotics against resistant bacteria, has collected USD 120 million from investors. The financing process took two tranches, law firm Wolf Theiss, which advised investors together with US firm Cooley, announced on Wednesday.

April 9, 2015

Vamed to Manage First Hospital in China

Vamed is about to establish and manage its first hospital in China - in the provincial capital Haikou on the island of Hainan.

March 30, 2015

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015

Pfizer's Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines Includes Facility in Austria

Pfizer Inc. announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.

August 1, 2014

Semperit to Realign Rubber Glove Production in Thailand

Listed chemicals group Semperit is realigning its rubber glove production activities in Thailand, i.e. the 50:50 joint venture with the Thai partner Sri Trang which runs a glove plant, Semperit said. The distribution will be realigned as of the turn of 2014 and 2015, while Semperit is also attempting to push through its rights in the JV at court, the company added.

July 18, 2014